InflaRx IFRX
NASDAQ IFRX
$1.55 +0.00 (+0.00%)
As of: Oct 22, 2026 · 11:10 AM EDT

InflaRx (IFRX) Long-Term Investments (2018)

Updated

InflaRx (IFRX) reported Long-Term Investments of $62.97 million for Q3 2018, up 560.2% from the prior quarter.

Analysis

InflaRx (IFRX) Long-Term Investments (2018) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,172.05 Bn 1,140.63 Bn 19.71 Bn 3.86 Bn
2 Johnson & Johnson 636.25 Bn 554.77 Bn 17.26 Bn -
3 AbbVie 503.38 Bn 476.49 Bn 12.70 Bn 266.00 Mn
4 Merck 377.92 Bn 332.30 Bn 12.21 Bn 1.22 Bn
5 Novartis Ag 304.19 Bn 268.18 Bn 11.24 Bn 69.00 Mn
6 Astrazeneca 267.24 Bn 240.93 Bn 12.86 Bn 297.00 Mn
7 Amgen 242.06 Bn 197.46 Bn 7.24 Bn -
8 Gilead Sciences 193.78 Bn 167.97 Bn 6.22 Bn -
9 Pfizer 172.54 Bn 119.18 Bn 10.94 Bn 1.56 Bn
10 InflaRx 104.97 Mn -228.65 Mn 2.74 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2018 63.01 Mn
Jun 30, 2018 9.24 Mn
API Access

InflaRx Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=IFRX&period=max&api_key=YOUR_API_KEY